Home
>
US Stocks
>
Editas Medicine Inc
Editas Medicine Inc
EDIT

Editas Medicine Inc (EDIT)

$37.7640.88%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
37.94
Today Low/High
36.89 / 38.03
52 Week Low/High
$27.01 / $99.95
P/E ratio
-25.025
Market Cap
$4.17B

Company Details

As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. For the latest information and scientific presentations, please visit www.editasmedicine.com.
Organisation
Editas Medicine Inc
Headquaters
Cambridge, Massachusetts, US
Employees
235
Industry
Health Technology
CEO
Cynthia Collins

Discover more

Frequently Asked Questions

What is Editas Medicine Inc (EDIT) share price today?

Can Indians buy Editas Medicine Inc (EDIT) shares?

How can I buy Editas Medicine Inc (EDIT) shares from India?

Can Fractional shares of Editas Medicine Inc (EDIT) be purchased?

What are the documents required to start investing in Editas Medicine Inc (EDIT) stocks?

We are a SEBI registered investement advisor